BioNTech SE (BNTX) Long-Term Deferred Tax (2020 - 2025)
BioNTech SE's Long-Term Deferred Tax history spans 6 years, with the latest figure at $15.7 million for Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax fell 82.0% to $15.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.7 million, a 82.0% decrease, with the full-year FY2025 number at $15.3 million, down 82.53% from a year prior.
- Long-Term Deferred Tax hit $15.7 million in Q4 2025 for BioNTech SE, down from $20.7 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for BNTX hit a ceiling of $346.5 million in Q3 2022 and a floor of $15.7 million in Q4 2025.
- Historically, Long-Term Deferred Tax has averaged $146.7 million across 5 years, with a median of $99.6 million in 2024.
- Biggest five-year swings in Long-Term Deferred Tax: dropped 0.19% in 2024 and later tumbled 82.0% in 2025.
- Tracing BNTX's Long-Term Deferred Tax over 5 years: stood at $170.9 million in 2021, then skyrocketed by 37.05% to $234.2 million in 2022, then tumbled by 62.66% to $87.5 million in 2023, then dropped by 0.19% to $87.3 million in 2024, then tumbled by 82.0% to $15.7 million in 2025.
- Business Quant data shows Long-Term Deferred Tax for BNTX at $15.7 million in Q4 2025, $20.7 million in Q3 2025, and $88.1 million in Q2 2025.